4.7 Article

Shigella OspC3 suppresses murine cytosolic LPS sensing

Journal

ISCIENCE
Volume 24, Issue 8, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.isci.2021.102910

Keywords

-

Funding

  1. National Institute of General Medical Sciences (NIGMS) [P20-GM103625]
  2. UAMS College of Medicine
  3. University of Arkansas for Medical Sciences (UAMS)
  4. Center for Microbial Pathogenesis and Host Inflammatory Responses (CMPHIR)

Ask authors/readers for more resources

Shigella flexneri employs OspC3 to inhibit caspase-11 activity, preventing pyroptosis and aiding in bacterial dissemination and evasion of clearance.
Shigella flexneri, a cytosol-invasive gram-negative pathogen, deploys an array of type III-secreted effector proteins to evade host cell defenses. Caspase-11 and its human ortholog caspase-4 detect cytosolic lipopolysaccharide (LPS) and trigger gasdermin D-mediated pyroptosis to eliminate intra-cytoplasmic bacterial threats. However, the role of caspase-11 in combating S. flexneri is unclear. The Shigella T3SS effector OspC3 reportedly suppresses cytosolic LPS sensing by inhibiting caspase-4 but not caspase-11 activity. Surprisingly, we found that S. flexneri also uses OspC3 to inhibit murine caspase-11 activity. Mechanistically, we found that OspC3 binds only to primed caspase-11. Importantly, we demonstrate that S. flexneri employs OspC3 to prevent caspase-11-mediated pyroptosis in neutrophils, enabling bacteria to disseminate and evade clearance following intraperitoneal challenge. In contrast, S. flexneri lacking OspC3 is attenuated in a caspase-11-and gasdermin D-dependent fashion. Overall, our study reveals that OspC3 suppresses cytosolic LPS detection in a broad array of mammals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available